Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?

Di Renzo, L; Merra, G; Esposito, E; De Lorenzo, A

Di Renzo, L; Merra, G; Esposito, E; De Lorenzo, A.

Di Renzo L; Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy. giuseppe.merra@uniroma2.it.

Eur Rev Med Pharmacol Sci ; 24(8): 4062-4063, 2020 04.

Article in English | MEDLINE | ID: covidwho-205656

Subject(s)

Gastrointestinal Tract; Pneumonia, Viral; Probiotics; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Probiotics / Gastrointestinal Tract Type of study: Experimental Studies Limits: Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2020 Document Type: Article Affiliation country: Eurrev_202004_20977

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google